QI
SYNH

QS Investors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

QS Investors’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,500
Closed -$307K – 1257
2020
Q4 		$307K Hold
4,500
– – ﹤0.01% 981
2020
Q3 		$240K Sell
4,500
-38,750
-90% -$2.31M ﹤0.01% 1008
2020
Q2 		$2.52M Sell
43,250
-1,600
-4% -$86K 0.04% 403
2020
Q1 		$1.77M Hold
44,850
– – 0.03% 466
2019
Q4 		$2.67M Sell
44,850
-1,221
-3% -$65.6K 0.03% 491
2019
Q3 		$2.45M Hold
46,071
– – 0.03% 489
2019
Q2 		$2.35M Sell
46,071
-35,589
-44% -$1.66M 0.03% 523
2019
Q1 		$4.23M Sell
81,660
-609
-0.7% -$29.5K 0.05% 322
2018
Q4 		$3.24M Hold
82,269
– – 0.04% 354
2018
Q3 		$4.24M Hold
82,269
– – 0.04% 332
2018
Q2 		$3.86M Sell
82,269
-883
-1% -$36.5K 0.04% 381
2018
Q1 		$2.95M Sell
83,152
-4,322
-5% -$169K 0.03% 436
2017
Q4 		$3.81M Sell
87,474
-763
-0.9% -$35.6K 0.04% 389
2017
Q3 		$4.62M Sell
88,237
-1,142
-1% -$63.7K 0.04% 337
2017
Q2 		$5.23M Sell
89,379
-10
-0% -$520 0.04% 296
2017
Q1 		$4.1M Sell
89,389
-9,300
-9% -$463K 0.04% 366
2016
Q4 		$5.19M Sell
98,689
-4,870
-5% -$236K 0.04% 331
2016
Q3 		$4.62M Buy
103,559
+4,668
+5% +$202K 0.04% 402
2016
Q2 		$3.77M Sell
98,891
-6,094
-6% -$268K 0.03% 477
2016
Q1 		$4.33M Sell
104,985
-53,658
-34% -$2.21M 0.04% 437
2015
Q4 		$7.7M Buy
158,643
+105,443
+198% +$4.69M 0.07% 245
2015
Q3 		$2.13M Buy
53,200
+29,300
+123% +$1.28M 0.02% 601
2015
Q2 		$959K Buy
+23,900
New +$825K 0.01% 767

Other funds holding SYNH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

QS Investors's SYNH Position: Q1 2021 in Review

QS Investors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2021, closing a stake of 4,500 shares — an estimated $307K sold.

QS Investors first reported a position in SYNH in Q2 2015 and held it in 23 quarters. The position peaked at $7.7M in Q4 2015. 319 funds tracked by Wall St. Rank hold SYNH as of Q1 2021.

  • QS Investors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2021 after selling out during the quarter.
  • QS Investors sold 4,500 Syneos Health, Inc. Class A Common Stock shares in Q1 2021, an estimated $307K.
  • QS Investors first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 23 quarters.
  • QS Investors's Syneos Health, Inc. Class A Common Stock position peaked at $7.7M in Q4 2015.
  • 319 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2021.

Based on QS Investors's 13F filing for Q1 2021, filed 13 May 2021.